entertainment -WSS

entertainment

author：hotspot 2025-10-02 01:07:48 - browse：39

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Wikipedia

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

Medicare Advantage's lean provider networks lead CMS complaints

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

A new initiative will help leaders fight the next pandemic

Plane’s emergency slide plummets from sky, hits Chicago home

The kidney, in all its complexity, is captured in a new atlas

Wikipedia

entertainment

explore

Dobbs anniversary: the lost opportunity of abortion as health care

How CO2 helps viruses stay alive longer in the air

Duchenne breakthrough therapy leaves behind pioneering families

Sutter Health’s antitrust win overturned by appeals court

Supreme Court strikes down use of affirmative action

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Duchenne breakthrough therapy leaves behind pioneering families

The kidney, in all its complexity, is captured in a new atlas

Affirmative action in medical school literally saved lives

Data don't support strong claims for Covid

hotspot

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

'Reaching a detente': STAT's Helen Branswell on covering Covid

'Reaching a detente': STAT's Helen Branswell on covering Covid

FDA approves Moderna’s RSV vaccine, its second licensed product

Resistance to cancer drugs: A new genetic explanation

FTC loses bid to block Novant's North Carolina hospital merger

hotspot

Wikipedia

leisure time

focus